Diabetes medicine feels the shift toward quality-weighted lifestyle disease management more than any other specialty.
The base points (760 for diabetes) are unchanged, but the enhanced management add-on introduces relative scoring, where HbA1c control rates, eye and dental attendance rates, and nephropathy follow-up rates decide which tier you land in. On top of that, coordination with ophthalmology and dentistry became billable in its own right.
1. What changed
| Item | Change | Old → New | Impact |
|---|---|---|---|
| Lifestyle disease management fee | Six-month blood testing requirement, signature abolished, new enhanced management add-on (30/20/10 pts). Outcome indicators such as HbA1c feed directly into relative scoring | (I) 760 pts (diabetes) unchanged (verify) | High |
| Ophthalmology and dental coordination add-ons (new) | Evaluates referral and coordination for diabetic patients needing eye or dental care (once per year) | 60 pts each, new (verify) | Medium |
| Eased exclusions for home self-injection guidance | Patients billed under lifestyle disease management with diabetes as the primary condition can now also be billed the home self-injection guidance fee for non-diabetes conditions | — (verify) | Medium |
| Diabetic nephropathy prevention guidance fee | Explicitly outside the bundle under fee (II) (concurrently billable). No change to base points identified | 350 pts (likely unchanged, verify) | Medium |
| isCGM moved into selective treatment | From 1 June 2026, isCGM can be offered on a self-pay basis to patients who do not meet insurance criteria (prediabetes, prevention). Web publication, in-clinic posting, and filing with the regional bureau are mandatory | Outside insurance (verify) | Medium |
2. What it means for the practice
Under relative scoring, a disease registry and a recall process for overdue patients are the conditions for reaching an upper tier. The gap between the top 20% and everyone else is 20 points — roughly 480,000 yen a year for a clinic billing 200 eligible patients a month.
The eye and dental coordination add-ons (60 points each, annually) are small per unit but accumulate with little effort once referral workflows are standardized. For a clinic with 200 diabetic patients billing both annually, that is 24,000 points — 240,000 yen a year. Because they also feed into complication-management quality, they influence the enhanced management tier as well. Conversely, "we do recommend retinal screening, but it isn't recorded" is a double loss.
Clarifying concurrent billing for the nephropathy prevention guidance fee raises the value of multidisciplinary teams (nurses, registered dietitians). Build guidance slots into the outpatient schedule.
isCGM in selective treatment can become a new revenue line for prediabetes and prevention — provided web publication, in-clinic posting, filing, and consent processes are in place first.
3. Practical checklist
- Can you record and extract eye and dental attendance for diabetic patients?
- Have you standardized referral letters and reply letters with eye and dental partners?
- Can you pull the last blood test date for patients billed under fee (I)?
- Are nephropathy prevention guidance slots built into the outpatient schedule?
- If offering isCGM under selective treatment, are web publication, posting, and filing complete?
4. Where an AI-native EMR fits — feature by feature
In 2026 this specialty is evaluated not on whether patients are seen, but on whether complication management can be demonstrated. Here is how Pottech's AI-native EMR helps, feature by feature.
Feature 1: Billing and claims management — treat annual and six-monthly limits as deadlines
The automatic billing engine checks bundling, mutual exclusions, and frequency limits.
Deadline-bound requirements cluster in this specialty: six-month blood testing under fee (I), annual eye and dental coordination add-ons, monthly nephropathy prevention guidance. Tracking who last had what, and when, from memory stops being realistic at a few hundred patients. Being able to extract the overdue list is what prevents unbilled work.
Feature 2: Management analytics dashboard — aim deliberately at a tier
Visit volumes, revenue per patient, and monthly trends are aggregated and visualized automatically.
The enhanced management add-on is scored relatively. Without monthly visibility into HbA1c control, eye attendance, dental attendance, and nephropathy follow-up, aiming for an upper tier is meaningless. Building a record during the transitional period (treated as tier 1 through March 2027) starts with knowing where you stand.
Feature 3: AI assistant — summarize trends in lab values
Diagnostic suggestions and differential diagnosis, plus lab value trend summaries and personalized patient explanations.
Diabetes management means following several long time series at once — HbA1c, glucose, renal function, lipids. Being able to summarize "what changed over the past six months," rather than reading a list of numbers, raises decision quality within a short consultation. Generated patient explanations also help with the persuasion work: the care plan, and referrals to eye and dental care.
Also review what applies to every specialty
Consultation fees, the inflation add-on, the wage increase evaluation fee, and the electronic clinical information coordination add-on are collected in "what applies to every specialty."
Sources (principal)
- MHLW, "About the FY2026 Fee Schedule Revision" https://www.mhlw.go.jp/stf/newpage_67729.html
- med-cpa, "Revisions to lifestyle disease management fees" https://med-cpa.jp/hoshu-13/
- Sasaki Research Institute, "Lifestyle disease management and the enhanced management add-on" https://www.sasakigp.co.jp/column/10029734
- Maeyamada Jun Shoten, "How lifestyle disease management changes in 2026 (eye and dental coordination, 60 pts)" https://www.maeyamadajun-shoten.com/blog/1030
- note, "isCGM under selective treatment" https://note.com/apotheke_umschau/n/naba2d27f7eb8